2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow NB-UVB phototherapy: new trials by email Literature Review of NB-UVB phototherapy trials Research Report on NB-UVB phototherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo Ruxolitinib 1.5% cream, NB-UVB phototherapy - Vitiligo | Phase 2 | Completed | Incyte Corporation | 55 | 2022-05-05 | 2025-02-20 |
| Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo Apremilast, NB-UVB phototherapy - Vitiligo | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 23 | 2017-04-14 | 2019-08-28 |
Vitiligo (2) · Hypopigmentation (1) · Pigmentation Disorders (1) · Skin Diseases (1)
Icahn School of Medicine at Mount Sinai (1) · Incyte Corporation (1)
United States (2) · Canada (1)
Haq Nawaz, MD (1) · Mark Lebwohl, MD (1)